XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Treasury Stock, At Cost
Notes Receivable From Stockholders
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at beginning of period at Jun. 30, 2022 $ 32 $ 393,157   $ (95) $ (2,687) $ (333,550) $ 56,857
Balance at beginning of period (in shares) at Jun. 30, 2022 31,930            
Interest on stockholders' notes       (1)     (1)
Issuance of common stock upon exercise of stock options   465         465
Issuance of common stock upon exercise of stock options (in shares) 129            
Issuance of common stock in connection with employee stock purchase plan   540         540
Issuance of common stock in connection with employee stock purchase plan (in shares) 72            
Stock-based compensation   3,836         3,836
Foreign currency translation adjustments         (206)   (206)
Net income (loss)           (120) (120)
Balance at end of period at Dec. 31, 2022 $ 32 397,998   (96) (2,893) (333,670) 61,371
Balance at end of period (in shares) at Dec. 31, 2022 32,131            
Balance at beginning of period at Sep. 30, 2022 $ 32 395,252   (95) (3,838) (333,566) 57,785
Balance at beginning of period (in shares) at Sep. 30, 2022 31,937            
Interest on stockholders' notes       (1)     (1)
Issuance of common stock upon exercise of stock options   435         435
Issuance of common stock upon exercise of stock options (in shares) 122            
Issuance of common stock in connection with employee stock purchase plan   540         540
Issuance of common stock in connection with employee stock purchase plan (in shares) 72            
Stock-based compensation   1,771         1,771
Foreign currency translation adjustments         945   945
Net income (loss)           (104) (104)
Balance at end of period at Dec. 31, 2022 $ 32 397,998   (96) (2,893) (333,670) 61,371
Balance at end of period (in shares) at Dec. 31, 2022 32,131            
Balance at beginning of period at Jun. 30, 2023 $ 32 401,087 $ (5,763) (97) (2,122) (331,441) $ 61,696
Balance at beginning of period (in shares) at Jun. 30, 2023 31,482   786        
Balance at beginning of period (in shares) at Jun. 30, 2023             786
Repayment on stockholder notes       77     $ 77
Issuance of common stock upon exercise of stock options   413         413
Issuance of common stock upon exercise of stock options (in shares) 124            
Repurchase of common stock     $ (3,015)       (3,015)
Repurchase of common stock, shares (474)   474        
Issuance of common stock in connection with employee stock purchase plan   417         417
Issuance of common stock in connection with employee stock purchase plan (in shares) 70            
Stock-based compensation   2,403         2,403
Foreign currency translation adjustments         21   21
Net income (loss)           4,781 4,781
Balance at end of period at Dec. 31, 2023 $ 32 404,320 $ (8,778) (20) (2,101) (326,660) $ 66,793
Balance at end of period (in shares) at Dec. 31, 2023 31,202   1,260        
Balance at end of period (in shares) at Dec. 31, 2023     1,260       1,260
Balance at beginning of period at Sep. 30, 2023 $ 32 402,299 $ (6,280) (64) (2,877) (328,845) $ 64,265
Balance at beginning of period (in shares) at Sep. 30, 2023 31,400            
Balance at beginning of period (in shares) at Sep. 30, 2023     869        
Repayment on stockholder notes       44     44
Issuance of common stock upon exercise of stock options   409         409
Issuance of common stock upon exercise of stock options (in shares) 123            
Repurchase of common stock     $ (2,498)       (2,498)
Repurchase of common stock, shares (391)   391        
Issuance of common stock in connection with employee stock purchase plan   417         417
Issuance of common stock in connection with employee stock purchase plan (in shares) 70            
Stock-based compensation   1,195         1,195
Foreign currency translation adjustments         776   776
Net income (loss)           2,185 2,185
Balance at end of period at Dec. 31, 2023 $ 32 $ 404,320 $ (8,778) $ (20) $ (2,101) $ (326,660) $ 66,793
Balance at end of period (in shares) at Dec. 31, 2023 31,202   1,260        
Balance at end of period (in shares) at Dec. 31, 2023     1,260       1,260